Omeros (OMER) EBT (2010 - 2026)
Omeros (OMER) reported EBT of $51.3 million for Q1 2026, up 236.58% on a YoY basis from $15.2 million in Q1 2025, and up 239.84% sequentially from -$36.7 million in Q4 2025.
Omeros (OMER) EBT (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of EBT data on file, last reported at $51.3 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 236.58% year-over-year to $51.3 million; the trailing twelve-month figure through Mar 2026 stood at -$76.8 million (up 61.05% YoY), and the FY2025 full-year result was -$2.8 million, up 98.45% from the prior year.
- EBT climbed to $51.3 million in Q1 2026, from -$36.7 million in the prior quarter.
- In the past five years, EBT ranged from a high of $51.3 million in Q1 2026 to a low of -$65.1 million in Q2 2024.
- A 5-year average of -$39.7 million and a median of -$43.8 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT sank 141.34% in 2022 and soared 236.58% in 2026, its largest moves.
- Tracing OMER's EBT over 5 years: stood at -$26.2 million in 2022, then slumped by 118.69% to -$57.4 million in 2023, then increased by 3.75% to -$55.2 million in 2024, then jumped by 33.59% to -$36.7 million in 2025, then jumped by 239.84% to $51.3 million in 2026.
- Business Quant data shows OMER's EBT at $51.3 million in Q1 2026, -$36.7 million in Q4 2025, and -$47.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Omeros | 707.67 Mn | 707.67 Mn | 9.31 Mn | 51.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51.31 Mn |
| Dec 31, 2025 | -36.69 Mn |
| Sep 30, 2025 | -47.43 Mn |
| Jun 30, 2025 | -43.98 Mn |
| Mar 31, 2025 | -37.57 Mn |
| Dec 31, 2024 | -55.24 Mn |
| Sep 30, 2024 | -39.23 Mn |
| Jun 30, 2024 | -65.13 Mn |
| Mar 31, 2024 | -43.85 Mn |
| Dec 31, 2023 | -57.40 Mn |
| Sep 30, 2023 | -51.66 Mn |
| Jun 30, 2023 | -44.29 Mn |
| Mar 31, 2023 | -39.68 Mn |
| Dec 31, 2022 | -26.25 Mn |
| Sep 30, 2022 | -54.79 Mn |
| Jun 30, 2022 | -41.70 Mn |
| Mar 31, 2022 | -40.52 Mn |
| Dec 31, 2021 | -105.16 Mn |
| Sep 30, 2021 | -22.70 Mn |
| Jun 30, 2021 | -79.34 Mn |